Literature DB >> 21278508

Breast cancer: epidemiology and risk factors.

Ashley Stuckey1.   

Abstract

Breast cancer is a worldwide problem affecting more than 1 million women annually. Currently, best care for women with breast cancer involves a multidisciplinary approach requiring a broad understanding of epidemiologic, genetic, prognostic, and predictive factors. This study will discuss the epidemiology and risk factors associated with breast cancer.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21278508     DOI： 10.1097/GRF.0b013e3182080056

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN： 0009-9201            Impact factor:   2.190


  19 in total

1.  EMP1, a member of a new family of antiproliferative genes in breast carcinoma.

Authors:  G G Sun; Y D Wang; Y F Lu; W N Hu
Journal:  Tumour Biol       Date:  2014-01-09

2.  Low PBRM1 identifies tumor progression and poor prognosis in breast cancer.

Authors:  Dan Mo; Chunhong Li; Junrong Liang; Qunfeng Shi; Naiwei Su; Shuyou Luo; Tian Zeng; Xinning Li
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 3.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Authors:  Nicole M Davis; Melissa Sokolosky; Kristin Stadelman; Steve L Abrams; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Jerry Polesel; Roberta Maestro; Antonino D'Assoro; Lyudmyla Drobot; Dariusz Rakus; Agnieszka Gizak; Piotr Laidler; Joanna Dulińska-Litewka; Joerg Basecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Giuseppe Montalto; Melchiorre Cervello; Timothy L Fitzgerald; Zoya Demidenko; Alberto M Martelli; Lucio Cocco; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2014-07-15

4.  Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis.

Authors:  Qiao-Hui Chen; Qing-Bing Wang; Bei Zhang
Journal:  Tumour Biol       Date:  2013-08-29

5.  Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.

Authors:  Yao-Min Chen; Yu Liu; Hai-Yan Wei; Ke-Zhen Lv; Peifen Fu
Journal:  Tumour Biol       Date:  2016-02-16

Review 6.  TP53 status and response to treatment in breast cancers.

Authors:  Mariana Varna; Guilhem Bousquet; Louis-François Plassa; Philippe Bertheau; Anne Janin
Journal:  J Biomed Biotechnol       Date:  2011-05-09

7.  Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden.

Authors:  G Frisk; T Svensson; L M Bäcklund; E Lidbrink; P Blomqvist; K E Smedby
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

8.  Lack of Association of the Fat Mass and Obesity Associated (FTO) Gene rs9939609 Polymorphism with Breast Cancer Risk: a Systematic Review and Meta-Analysis Based on Case - Control Studies

Authors:  Jamal Jafari Nedooshan; Saeed Kargar; Hossein Neamatzadeh; Fatemeh Haghighi; Reihaneh Dehghani Mohammad Abadi; Niloofar Seddighi
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

Review 9.  Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies.

Authors:  Manfred Schmitt; Viktor Magdolen; Feng Yang; Marion Kiechle; Jane Bayani; George M Yousef; Andreas Scorilas; Eleftherios P Diamandis; Julia Dorn
Journal:  Radiol Oncol       Date:  2013-10-08       Impact factor: 2.991

10.  Copper (II) and 2,2'-bipyridine complexation improves chemopreventive effects of naringenin against breast tumor cells.

Authors:  Júlio César Conceição Filho; André Lúcio Franceschini Sarria; Amanda Blanque Becceneri; Angelina Maria Fuzer; Jaqueline Raquel Batalhão; Caio Marcio Paranhos da Silva; Rose Maria Carlos; Paulo Cezar Vieira; João Batista Fernandes; Márcia Regina Cominetti
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.